Giuseppe
Emeritus
Negotiating Equitable Access to Influenza Vaccines: Global Health Diplomacy and the Controversies Surrounding Avian Influenza H5N1 and Pandemic Influenza H1N1 (PLoS, extract, edited)
[Source: PLoS, full PDF Document (LINK). Extract, edited.]
Negotiating Equitable Access to Influenza Vaccines: Global Health Diplomacy and the Controversies Surrounding Avian Influenza H5N1 and Pandemic Influenza H1N1
As part of the PLoS Medicine series on Global Health Diplomacy, David Fidler provides a case study of the difficult negotiations to increase equitable access to vaccines for highly pathogenic avian influenza A (H5N1) and pandemic 2009 influenza
David P. Fidler*
Maurer School of Law, Indiana University, Bloomington, Indiana, United States of America
Citation: Fidler DP (2010) Negotiating Equitable Access to Influenza Vaccines: Global Health Diplomacy and the Controversies Surrounding Avian Influenza H5N1 and Pandemic Influenza H1N1. PLoS Med 7(5): e1000247. doi:10.1371/journal.pmed.1000247
Academic Editor: Kelley Lee, London School of Hygiene & Tropical Medicine, United Kingdom
Published: May 4, 2010
Copyright: ? 2010 David P. Fidler. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: No specific funding was received to write this piece.
Competing interests: The author has declared that no competing interests exist.
Abbreviations: 2009-H1N1, pandemic 2009 influenza A (H1N1); HPAI-H5N1, highly pathogenic avian influenza A (H5N1); IGM, Intergovernmental Meeting; SMTA, Standard Material Transfer Agreement; UN, United Nations; UNCLOS, UN Convention on the Law of the Sea; WHO, World Health Organization
* E-mail: dfidler@indiana.edu
Dr. Fidler is James Louis Calamaras Professor of Law and Director, Center on American and Global Security, Indiana University.
Provenance: Commissioned; externally peer reviewed. This article is part of the PLoS Medicine Global Health Diplomacy series.
Introduction
One of the most controversial areas of global health diplomacy over the past five years has involved negotiations to increase equitable access to vaccines for highly pathogenic avian influenza A (H5N1) (HPAI-H5N1) and pandemic 2009 influenza A (H1N1) (2009-H1N1). The limited results produced by these negotiations have stimulated calls for a new global framework to improve equitable access to influenza vaccines. The prospects for such a framework are not, however, promising, because the national interests of most developed states vis-?-vis dangerous influenza strains favor retaining the existing imbalanced, reactive, and ad hoc approach to vaccine access. This article examines why negotiating equitable access to influenza vaccines in the context of HPAI-H5N1 and 2009-H1N1 has been, and promises to continue to be, a difficult diplomatic endeavor.
(...)
-
-----
[Source: PLoS, full PDF Document (LINK). Extract, edited.]
Negotiating Equitable Access to Influenza Vaccines: Global Health Diplomacy and the Controversies Surrounding Avian Influenza H5N1 and Pandemic Influenza H1N1
As part of the PLoS Medicine series on Global Health Diplomacy, David Fidler provides a case study of the difficult negotiations to increase equitable access to vaccines for highly pathogenic avian influenza A (H5N1) and pandemic 2009 influenza
David P. Fidler*
Maurer School of Law, Indiana University, Bloomington, Indiana, United States of America
Citation: Fidler DP (2010) Negotiating Equitable Access to Influenza Vaccines: Global Health Diplomacy and the Controversies Surrounding Avian Influenza H5N1 and Pandemic Influenza H1N1. PLoS Med 7(5): e1000247. doi:10.1371/journal.pmed.1000247
Academic Editor: Kelley Lee, London School of Hygiene & Tropical Medicine, United Kingdom
Published: May 4, 2010
Copyright: ? 2010 David P. Fidler. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: No specific funding was received to write this piece.
Competing interests: The author has declared that no competing interests exist.
Abbreviations: 2009-H1N1, pandemic 2009 influenza A (H1N1); HPAI-H5N1, highly pathogenic avian influenza A (H5N1); IGM, Intergovernmental Meeting; SMTA, Standard Material Transfer Agreement; UN, United Nations; UNCLOS, UN Convention on the Law of the Sea; WHO, World Health Organization
* E-mail: dfidler@indiana.edu
Dr. Fidler is James Louis Calamaras Professor of Law and Director, Center on American and Global Security, Indiana University.
Provenance: Commissioned; externally peer reviewed. This article is part of the PLoS Medicine Global Health Diplomacy series.
Introduction
One of the most controversial areas of global health diplomacy over the past five years has involved negotiations to increase equitable access to vaccines for highly pathogenic avian influenza A (H5N1) (HPAI-H5N1) and pandemic 2009 influenza A (H1N1) (2009-H1N1). The limited results produced by these negotiations have stimulated calls for a new global framework to improve equitable access to influenza vaccines. The prospects for such a framework are not, however, promising, because the national interests of most developed states vis-?-vis dangerous influenza strains favor retaining the existing imbalanced, reactive, and ad hoc approach to vaccine access. This article examines why negotiating equitable access to influenza vaccines in the context of HPAI-H5N1 and 2009-H1N1 has been, and promises to continue to be, a difficult diplomatic endeavor.
(...)
-
-----